PharmaIntellect - Pharma Deals

by Unknown on Friday 26 July 2013

PharmaIntellect - Pharma Deals

Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property for Bleeding and Clotting Disorder Functional Antibiotic Drug Candidate

Posted: 25 Jul 2013 10:41 PM PDT

Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY), which is focused on the commercialization of drug formulations utilizing the FDA 505(b)(2) drug development pathway, announced that as part of the...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]